Highly qualified providers offer Exosome Therapy treatments through injection, intravenous, nebulizer, or intranasal. Often, exosomes and mesenchymal stem cells are infused together for optimal results. These exosomes used by R3 Stem Cell Therapy are derived specifically from umbilical cord stem cells. These cells are produced in cGMP-compliant labs (Current Good Manufacturing Practice). The quality assurance standards are equitable to the necessary regulations provided by the US FDA (Food & Drug Administration). According to David Greene, the Founder, and CEO of R3 Stem Cell Therapy,

R3 Stem Cell is delivering effective and safe regenerative therapies in the US & internationally. The company offers products and services internationally to both patients and providers. Regenerative therapies are offered through clinics, and training workshops provide providers with information about regenerative biologics. In addition, R3 stem cell now has sister companies offering products for distribution, practice marketing, and clinical trial research studies around the world.